trial_id stringlengths 11 11 | question stringlengths 154 5.24k | options dict | answer stringclasses 4
values | trials listlengths 4 4 | id int64 0 27.3k | split stringclasses 2
values |
|---|---|---|---|---|---|---|
NCT00000611 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women. The three major components of the WHI are:... | {
"A": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Ethinylestradiol / Norethisterone | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Estradiol / Progesterone | Intervention Type: DRUG; Name: Ethinylestradiol / Norethisterone; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Estradiol / Prog... | C | [
"NCT00732693",
"NCT00134745",
"NCT00000611",
"NCT00837616"
] | 100 | train |
NCT00000611 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To address cardiovascular disease, cancer, and osteoporosis, the most common causes of death, disability, and impaired quality of life in postmenopausal women. The three major components of the WHI are:... | {
"A": "Intervention Type: DRUG; Name: hormone replacement therapy; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogens; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: progestins; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogen replacement therapy; Assigned to Arm(s): N/A | ... | A | [
"NCT00000611",
"NCT01017783",
"NCT00000616",
"NCT00470119"
] | 101 | train |
NCT00000615 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To develop and test interventions to prevent obesity by decreasing weight gain during the high-risk transitional period from pre-puberty to puberty in African-American girls who are at high risk for dev... | {
"A": "Arm Label: Consumer Support; Type: EXPERIMENTAL; Interventions: Other: Control condition | Arm Label: Consumer Support with Effectiveness Info; Type: EXPERIMENTAL; Interventions: Other: Effectiveness of Labels in Reducing Purchasing of Sugar Sweetened Beverages | Intervention Type: OTHER; Name: Effectiveness ... | C | [
"NCT02947802",
"NCT00153322",
"NCT00000615",
"NCT02744859"
] | 102 | train |
NCT00000615 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To develop and test interventions to prevent obesity by decreasing weight gain during the high-risk transitional period from pre-puberty to puberty in African-American girls who are at high risk for dev... | {
"A": "Intervention Type: BEHAVIORAL; Name: diet, reducing; Assigned to Arm(s): N/A",
"B": "Arm Label: \"Fortaleça sua Saúde\" program; Type: EXPERIMENTAL; Interventions: Behavioral: \"Fortaleça sua Saúde\" program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Nam... | A | [
"NCT00000615",
"NCT02439827",
"NCT00108901",
"NCT01704768"
] | 103 | train |
NCT00000615 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To develop and test interventions to prevent obesity by decreasing weight gain during the high-risk transitional period from pre-puberty to puberty in African-American girls who are at high risk for dev... | {
"A": "Intervention Type: BEHAVIORAL; Name: diet, reducing; Assigned to Arm(s): N/A",
"B": "Arm Label: NewNordicDiet first; Type: OTHER; Interventions: Other: School meals based on the principles of the New Nordic Diet | Arm Label: NewNordicDiet last; Type: OTHER; Interventions: Other: School meals based on the pr... | A | [
"NCT00000615",
"NCT01457794",
"NCT01704768",
"NCT01192100"
] | 104 | train |
NCT00000615 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To develop and test interventions to prevent obesity by decreasing weight gain during the high-risk transitional period from pre-puberty to puberty in African-American girls who are at high risk for dev... | {
"A": "Arm Label: Low intensity arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Dietary, physical activity and sleeping | Arm Label: High intensity arm; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary, physical activity and sleeping | Intervention Type: BEHAVIORAL; Name: Dietary, physical activity an... | D | [
"NCT01198847",
"NCT00988754",
"NCT02244424",
"NCT00000615"
] | 105 | train |
NCT00000616 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To compare the effectiveness of advice versus two multicomponent lifestyle interventions to control blood pressure in participants with Stage 1 hypertension or higher than optimal blood pressure.
| {
"A": "Arm Label: Low carbohydrate diet (F); Type: EXPERIMENTAL; Interventions: Dietary Supplement: Low carbohydrate - high fat diet | Arm Label: Traditional diet (K); Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: High carbohydrate - low fat diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Low carbo... | C | [
"NCT01005498",
"NCT00069784",
"NCT00000616",
"NCT00000611"
] | 106 | train |
NCT00000616 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To compare the effectiveness of advice versus two multicomponent lifestyle interventions to control blood pressure in participants with Stage 1 hypertension or higher than optimal blood pressure.
| {
"A": "Intervention Type: BEHAVIORAL; Name: diet, sodium-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, fat-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, reducing; Assigned to... | A | [
"NCT00000616",
"NCT00924937",
"NCT01725945",
"NCT00230919"
] | 107 | train |
NCT00000616 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To compare the effectiveness of advice versus two multicomponent lifestyle interventions to control blood pressure in participants with Stage 1 hypertension or higher than optimal blood pressure.
| {
"A": "Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Mediterranean diet | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Low-fat diet | Intervention Type: OTHER; Name: Mediterranean diet; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: Low-fat diet; Assigned to Arm(s): 2",
"B":... | D | [
"NCT00725257",
"NCT00622960",
"NCT00992641",
"NCT00000616"
] | 108 | train |
NCT00000616 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To compare the effectiveness of advice versus two multicomponent lifestyle interventions to control blood pressure in participants with Stage 1 hypertension or higher than optimal blood pressure.
| {
"A": "Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Caloric Restriction; Type: OTHER; Interventions: Behavioral: behavioral dietary intervention | Arm Label: Exercise Intervention; Type: OTHER; Interventions: Behavioral: Exercise intervention | Arm Label: Caloric Restriction AND Exercis... | B | [
"NCT00470119",
"NCT00000616",
"NCT00124553",
"NCT00621205"
] | 109 | train |
NCT00000616 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To compare the effectiveness of advice versus two multicomponent lifestyle interventions to control blood pressure in participants with Stage 1 hypertension or higher than optimal blood pressure.
| {
"A": "Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: intervention group; Type: EXPERIMENTAL; Interventions: Dietary Supplement: artificially sweetened beverages | Intervention Type: DIETARY_SUPPLEMENT; Name: artificially sweetened beverages; Assigned to Arm(s): intervention group",... | D | [
"NCT03679689",
"NCT00777647",
"NCT00779571",
"NCT00000616"
] | 110 | train |
NCT00000616 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To compare the effectiveness of advice versus two multicomponent lifestyle interventions to control blood pressure in participants with Stage 1 hypertension or higher than optimal blood pressure.
| {
"A": "Intervention Type: BEHAVIORAL; Name: diet, sodium-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, fat-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: exercise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, reducing; Assigned to... | A | [
"NCT00000616",
"NCT00622960",
"NCT00003787",
"NCT00000611"
] | 111 | train |
NCT00000616 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To compare the effectiveness of advice versus two multicomponent lifestyle interventions to control blood pressure in participants with Stage 1 hypertension or higher than optimal blood pressure.
| {
"A": "Arm Label: Intervention - PilAm Go4Health Program; Type: EXPERIMENTAL; Interventions: Behavioral: PilAm Go4Health Weight-loss Program | Arm Label: Active control - pedometer only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Control | Intervention Type: BEHAVIORAL; Name: PilAm Go4Health Weight-l... | B | [
"NCT02290184",
"NCT00000616",
"NCT01766700",
"NCT02643576"
] | 112 | train |
NCT00000616 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To compare the effectiveness of advice versus two multicomponent lifestyle interventions to control blood pressure in participants with Stage 1 hypertension or higher than optimal blood pressure.
| {
"A": "Intervention Type: BEHAVIORAL; Name: dietary intervention; Assigned to Arm(s): N/A",
"B": "Intervention Type: DRUG; Name: hormone replacement therapy; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogens; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: progestins; Assigned to Arm(s): ... | C | [
"NCT00160108",
"NCT00000611",
"NCT00000616",
"NCT02062424"
] | 113 | train |
NCT00000616 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To compare the effectiveness of advice versus two multicomponent lifestyle interventions to control blood pressure in participants with Stage 1 hypertension or higher than optimal blood pressure.
| {
"A": "Arm Label: High MUFA diet; Type: EXPERIMENTAL; Interventions: Other: High-MUFA diet | Arm Label: High CHO diet; Type: ACTIVE_COMPARATOR; Interventions: Other: High-CHO diet | Intervention Type: OTHER; Name: High-MUFA diet; Assigned to Arm(s): High MUFA diet | Intervention Type: OTHER; Name: High-CHO diet; Ass... | D | [
"NCT00622960",
"NCT00274729",
"NCT00276939",
"NCT00000616"
] | 114 | train |
NCT00000616 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To compare the effectiveness of advice versus two multicomponent lifestyle interventions to control blood pressure in participants with Stage 1 hypertension or higher than optimal blood pressure.
| {
"A": "Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: Weight loss intervention | Arm Label: Control Group (delayed intervention); Type: EXPERIMENTAL; Interventions: Other: Weight loss intervention | Intervention Type: OTHER; Name: Weight loss intervention; Assigned to Arm(s): Control Group ... | D | [
"NCT01470222",
"NCT00000611",
"NCT01017783",
"NCT00000616"
] | 115 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Blood pressure; Type: EXPERIMENTAL; Interventions: Drug: Losartan, Losartan and HCTZ, Amlodipine , Spironolactone | Intervention Type: DRUG; Name: Losartan, Losartan and HCTZ, Amlodipine , Spironolactone; Assigned to Arm(s): Blood pressure",
"B": "Arm Label: SBP < 145-135 mmHg and LDL-C 2.8 - 1.8... | D | [
"NCT01198496",
"NCT01563731",
"NCT01650402",
"NCT00000620"
] | 116 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Standard glycemic control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin, Drug: Glimepiride, Drug: Rosiglitazone, Drug: Metformin | Arm Label: Intensive glycemic control; Type: EXPERIMENTAL; Interventions: Drug: Insulin, Drug: Glimepiride, Drug: Rosiglitazone, Drug: Metformin | Intervention... | C | [
"NCT00032487",
"NCT00145925",
"NCT00000620",
"NCT01889095"
] | 117 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Glycemia Trial: intensive control; Type: EXPERIMENTAL; Interventions: Drug: Anti-hyperglycemic Agents | Arm Label: Glycemia Trial: standard control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Anti-hyperglycemic Agents | Arm Label: BP Trial: intensive control; Type: EXPERIMENTAL; Interventions: D... | A | [
"NCT00000620",
"NCT00133692",
"NCT01563731",
"NCT00421863"
] | 118 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Observation (Prompt Sham); Type: SHAM_COMPARATOR; Interventions: Procedure: Prompt Sham, Procedure: Deferred laser, Drug: Deferred aflibercept | Arm Label: Prompt aflibercept; Type: EXPERIMENTAL; Interventions: Drug: Prompt aflibercept, Procedure: Deferred laser, Drug: Deferred aflibercept | Interv... | B | [
"NCT02634333",
"NCT00000620",
"NCT02718326",
"NCT01489189"
] | 119 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Glycemia Trial: intensive control; Type: EXPERIMENTAL; Interventions: Drug: Anti-hyperglycemic Agents | Arm Label: Glycemia Trial: standard control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Anti-hyperglycemic Agents | Arm Label: BP Trial: intensive control; Type: EXPERIMENTAL; Interventions: D... | A | [
"NCT00000620",
"NCT03157414",
"NCT01394952",
"NCT02591849"
] | 120 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Intervention Type: DRUG; Name: Indapamide SR 1.5mg; Perindopril 2-4mg; Assigned to Arm(s): N/A",
"B": "Arm Label: SBP < 145-135 mmHg and LDL-C 2.8 - 1.8 mmol/l; Type: OTHER; Interventions: Drug: all approved antihypertensive drugs; all approved statins | Arm Label: SBP < 135-125 mmHg and LDL-C 2.8 - 1.8 mmo... | D | [
"NCT00122811",
"NCT01563731",
"NCT01650402",
"NCT00000620"
] | 121 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: intensive blood pressure control; Type: ACTIVE_COMPARATOR; Interventions: Drug: control systolic blood pressure less than 120 mmHg | Arm Label: standard blood pressure control; Type: ACTIVE_COMPARATOR; Interventions: Drug: control systolic blood pressure less than 140 mmHg | Intervention Type: DRUG... | C | [
"NCT01230216",
"NCT00523549",
"NCT00000620",
"NCT01164371"
] | 122 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Linagliptin; Type: EXPERIMENTAL; Interventions: Drug: Linagliptin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Linagliptin; Assigned to Arm(s): Linagliptin",
"B":... | B | [
"NCT00954447",
"NCT00000620",
"NCT01582230",
"NCT00286429"
] | 123 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Pioglitazone | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Pioglitazone; Assigned to Arm(s): 1",
"B": "Arm Label: Glycemia Trial: intensive control; Type: EXPERIMENTAL; Interventions: Drug: Anti-hyperglycemic... | B | [
"NCT00598013",
"NCT00000620",
"NCT00980356",
"NCT00145925"
] | 124 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Nurse administered; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse administered | Arm Label: Nurse & BP monitor; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse administered, Device: BP Monitor | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home BP Monito... | C | [
"NCT00129103",
"NCT00252720",
"NCT00000620",
"NCT00542178"
] | 125 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Blood pressure; Type: PLACEBO_COMPARATOR; Interventions: Drug: Perindopril-indapamide | Arm Label: Glucose control; Type: OTHER; Interventions: Drug: Gliclazide MR-based glucose lowering | Intervention Type: DRUG; Name: Perindopril-indapamide; Assigned to Arm(s): Blood pressure | Intervention Type:... | D | [
"NCT00145925",
"NCT01489189",
"NCT00542178",
"NCT00000620"
] | 126 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: intensive blood pressure control; Type: ACTIVE_COMPARATOR; Interventions: Drug: control systolic blood pressure less than 120 mmHg | Arm Label: standard blood pressure control; Type: ACTIVE_COMPARATOR; Interventions: Drug: control systolic blood pressure less than 140 mmHg | Intervention Type: DRUG... | B | [
"NCT01230216",
"NCT00000620",
"NCT01104311",
"NCT03015311"
] | 127 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: linagliptin 5mg; Type: EXPERIMENTAL; Interventions: Drug: Linagliptin 5mg | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo | Intervention Type: DRUG; Name: Linagliptin 5mg; Assigned to Arm(s): linaglip... | D | [
"NCT01792518",
"NCT01194830",
"NCT00542178",
"NCT00000620"
] | 128 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Intensive glycemia control; Type: EXPERIMENTAL; Interventions: Drug: Hypoglycemic Agents | Arm Label: Standard glycemia control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Standard glycemia control | Arm Label: Intensive BP control; Type: EXPERIMENTAL; Interventions: Drug: Intensive BP treatment... | D | [
"NCT00542178",
"NCT00143949",
"NCT00252694",
"NCT00000620"
] | 129 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Intervention Type: BEHAVIORAL; Name: Insulin; Assigned to Arm(s): N/A",
"B": "Arm Label: Standard glycemic control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin, Drug: Glimepiride, Drug: Rosiglitazone, Drug: Metformin | Arm Label: Intensive glycemic control; Type: EXPERIMENTAL; Interventions: Drug:... | D | [
"NCT00360815",
"NCT00032487",
"NCT00145925",
"NCT00000620"
] | 130 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Standard Treatment Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Diet, Behavioral: Exercise, Behavioral: Stop smoking, Drug: Glucose lowering therapy, Drug: Blood pressure lowering therapy, Drug: Lipid lowering therapy | Arm Label: Intensive Treatment Arm; Type: EXPERIMENTAL; Interventio... | C | [
"NCT00320008",
"NCT00542178",
"NCT00000620",
"NCT00360893"
] | 131 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Glargine insulin; Type: EXPERIMENTAL; Interventions: Drug: Glargine insulin | Arm Label: NPH insulin; Type: ACTIVE_COMPARATOR; Interventions: Drug: NPH insulin | Intervention Type: DRUG; Name: Glargine insulin; Assigned to Arm(s): Glargine insulin | Intervention Type: DRUG; Name: NPH insulin; Assig... | C | [
"NCT02451917",
"NCT01131676",
"NCT00000620",
"NCT02967211"
] | 132 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Antiplatelet; Type: ACTIVE_COMPARATOR; Interventions: Drug: aspirin, Drug: clopidogrel, Other: placebo | Arm Label: Blood pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Target of Blood Pressure | Intervention Type: DRUG; Name: aspirin; Assigned to Arm(s): Antiplatelet | Intervention Type:... | D | [
"NCT00059306",
"NCT00421863",
"NCT00133692",
"NCT00000620"
] | 133 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: SANDS Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: SANDS Intervention Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: FDA approved drugs to treat blood pressure and cholesterol | Intervention Type: DRUG; Name: FDA approved drugs to treat blood pressure and cholesterol;... | B | [
"NCT00047424",
"NCT00000620",
"NCT00133692",
"NCT00153101"
] | 134 | train |
NCT00000620 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Brief Summary: The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes ... | {
"A": "Arm Label: Standard glycemic control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin, Drug: Glimepiride, Drug: Rosiglitazone, Drug: Metformin | Arm Label: Intensive glycemic control; Type: EXPERIMENTAL; Interventions: Drug: Insulin, Drug: Glimepiride, Drug: Rosiglitazone, Drug: Metformin | Intervention... | B | [
"NCT00032487",
"NCT00000620",
"NCT00145925",
"NCT00147758"
] | 135 | train |
NCT00000622 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma pheno... | {
"A": "Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Montelukast | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo granules | Intervention Type: DRUG; Name: Montelukast; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo granules; Assigned to Arm(s): 2",
"B": "Interve... | B | [
"NCT00524693",
"NCT00000622",
"NCT00934713",
"NCT00076973"
] | 136 | train |
NCT00000622 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma pheno... | {
"A": "Intervention Type: DRUG; Name: inhaled fluticasone 750 mcg/day twice daily until 2 days without symptoms (maximum 15 consecutive days); Assigned to Arm(s): N/A",
"B": "Intervention Type: DRUG; Name: inhaled corticosteroids; Assigned to Arm(s): N/A",
"C": "Intervention Type: DRUG; Name: Montelukast (drug);... | B | [
"NCT00238927",
"NCT00000622",
"NCT00196547",
"NCT01142505"
] | 137 | train |
NCT00000622 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma pheno... | {
"A": "Arm Label: Placebo Budesonide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Budesonide, Drug: Placebo Budesonide | Arm Label: Budesonide; Type: EXPERIMENTAL; Interventions: Drug: Budesonide, Drug: Placebo Budesonide | Intervention Type: DRUG; Name: Budesonide; Assigned to Arm(s): Budesonide, Placebo Budesoni... | D | [
"NCT00675584",
"NCT00238927",
"NCT00497523",
"NCT00000622"
] | 138 | train |
NCT00000622 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma pheno... | {
"A": "Intervention Type: DRUG; Name: inhaled fluticasone 750 mcg/day twice daily until 2 days without symptoms (maximum 15 consecutive days); Assigned to Arm(s): N/A",
"B": "Intervention Type: DRUG; Name: Budesonide/formoterol; Assigned to Arm(s): N/A",
"C": "Arm Label: Symptom-based adjustment; Type: EXPERIMEN... | D | [
"NCT00238927",
"NCT00290264",
"NCT00495157",
"NCT00000622"
] | 139 | train |
NCT00000622 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma pheno... | {
"A": "Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: Comparator: placebo (unspecified) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: montelukast sodium | Intervention Type: DRUG; Name: montelukast sodium; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Comparator: placebo (unspe... | C | [
"NCT00117338",
"NCT00565955",
"NCT00000622",
"NCT00092989"
] | 140 | train |
NCT00000622 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma pheno... | {
"A": "Arm Label: Omalizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Omalizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Omalizumab; Assigned to Arm(s): Omalizumab | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo",
"B"... | D | [
"NCT00454051",
"NCT00545844",
"NCT00461032",
"NCT00000622"
] | 141 | train |
NCT00000867 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II, Randomized, Double Blind, Placebo-Controlled Trial of Memantine for AIDS Dementia Complex (ADC) as Concurrent Treatment With Antiretroviral Therapy
Brief Summary: The purpose of this study is to determine the ... | {
"A": "Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Memantine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Donepezil | Intervention Type: DRUG; Name: Memantine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Donepezil; Assigned to Arm(s): 2",
"B": "Intervention Type: DRUG; N... | B | [
"NCT00505167",
"NCT00000867",
"NCT00300716",
"NCT00235716"
] | 142 | train |
NCT00000923 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment Rollover for Subjects Formerly on ACTG 328 With Subcutaneous Interleukin-2 (IL-2) in Combination With Highly Active Antiretroviral Therapy (HAART)
Brief Summary: This study examines the long-term effects of inte... | {
"A": "Arm Label: Antiretroviral therapy alone; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Proleukin plus antiretroviral therapy; Type: EXPERIMENTAL; Interventions: Drug: Proleukin | Intervention Type: DRUG; Name: Proleukin; Assigned to Arm(s): Proleukin plus antiretroviral therapy",
"B": "Arm Label: N... | D | [
"NCT00013611",
"NCT00110812",
"NCT00004978",
"NCT00000923"
] | 143 | train |
NCT00001174 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Bipolar Genetics: A Collaborative Study
Brief Summary: This study looks to identify genes that may affect a person's chances of developing bipolar disorder (BP) and related conditions....
| {
"A": "Arm Label: Placebo (Slow Metabolizers); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Varenicline (Slow Metabolizers); Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline | Arm Label: Transdermal Nicotine (Slow Metabolizers); Type: ACTIVE_COMPARATOR; Interventions: Drug: Transderma... | D | [
"NCT01314001",
"NCT00364156",
"NCT00734617",
"NCT00001174"
] | 144 | train |
NCT00001195 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Endocrine Studies of Healthy Children
Brief Summary: Researchers would like to determine normal ranges for hormone levels and to learn more about the genetics involved in hormone production and action. Researchers will ta... | {
"A": "Arm Label: Glucosanol; Type: ACTIVE_COMPARATOR; Interventions: Device: Glucosanol | Intervention Type: DEVICE; Name: Glucosanol; Assigned to Arm(s): Glucosanol",
"B": "Arm Label: Exenatide; Type: EXPERIMENTAL; Interventions: Drug: Exenatide | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | I... | C | [
"NCT01435278",
"NCT00886626",
"NCT00001195",
"NCT00001723"
] | 145 | train |
NCT00001221 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-Blind, Randomized, Placebo-Controlled Trial of the Effect of Biosynthetic Growth Hormone and/or Ethinyl Estradiol on Adult Height in Patients With Turner Syndrome
Brief Summary: Turners Syndrome is a genetic cond... | {
"A": "Arm Label: 4 mg estradiol; Type: ACTIVE_COMPARATOR; Interventions: Drug: estradiol | Arm Label: 2 mg estradiol; Type: PLACEBO_COMPARATOR; Interventions: Drug: estradiol | Intervention Type: DRUG; Name: estradiol; Assigned to Arm(s): 2 mg estradiol, 4 mg estradiol",
"B": "Intervention Type: DRUG; Name: Growt... | B | [
"NCT00134745",
"NCT00001221",
"NCT00732693",
"NCT00837616"
] | 146 | train |
NCT00001406 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Eosinophil Activation and Function in Parasitic Infections and Other Conditions With Increased Tissue or Peripheral Blood Eosinophilia in Humans
Brief Summary: This study will investigate how, why and under what condition... | {
"A": "Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Reslizumab 3.0 mg/kg; Type: EXPERIMENTAL; Interventions: Drug: Reslizumab | Intervention Type: DRUG; Name: Reslizumab; Assigned to Arm(s): Reslizumab 3.0 mg/kg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): ... | C | [
"NCT01287039",
"NCT00436670",
"NCT00001406",
"NCT02452190"
] | 147 | train |
NCT00001522 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Population Differences in the Insulin Sensitivity, Resting Energy Expenditure, and Body Composition of Overweight Children and Children of Overweight Parents
Brief Summary: This study focuses on the way weight is gained. ... | {
"A": "Arm Label: Exenatide; Type: EXPERIMENTAL; Interventions: Drug: Exenatide | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Exenatide; Assigned to Arm(s): Exenatide",
"B": "Intervention Type: BEHAVIORAL; Name: Interpersonal Psychotherapy; Assigned to Arm(s): N/A... | C | [
"NCT00886626",
"NCT00680979",
"NCT00001522",
"NCT00234832"
] | 148 | train |
NCT00001723 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Safety and Efficacy of Orlistat (Xenical, Hoffmann LaRoche) in African American and Caucasian Children and Adolescents With Obesity-Related Comorbid Conditions
Brief Summary: Obesity is a condition affecting one-third off... | {
"A": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Metformin | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Metformin, Drug: Rosiglitazone | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Metformin, Behavioral: Lifestyle Program | Intervention Type: DRUG; Name: Metformin; Assigned to Arm... | D | [
"NCT00081328",
"NCT01425905",
"NCT00001195",
"NCT00001723"
] | 149 | train |
NCT00002476 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Randomized Study of Radiotherapy Alone vs With Concurrent Chemotherapy With MTX or VBMF (VCR/BLEO/MTX/5-FU) vs Subsequent Chemotherapy vs Concurrent and Subsequent Chemotherapy in Patients With Advanced Head and... | {
"A": "Arm Label: Arm I; Type: EXPERIMENTAL; Interventions: Drug: carboplatin, Drug: cisplatin, Drug: docetaxel, Drug: fluorouracil | Arm Label: Arm II; Type: EXPERIMENTAL; Interventions: Drug: cisplatin | Intervention Type: DRUG; Name: carboplatin; Assigned to Arm(s): Arm I | Intervention Type: DRUG; Name: cisplati... | C | [
"NCT00095875",
"NCT00004227",
"NCT00002476",
"NCT00273546"
] | 150 | train |
NCT00002523 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: FOUR ARMS PHASE III CLINICAL TRIAL FOR T3-T4 RESECTABLE RECTAL CANCER COMPARING PRE-OPERATIVE PELVIC IRRADIATION TO PRE-OPERATIVE IRRADIATION COMBINED WITH FLUOROURACIL AND LEUCOVORIN WITH OR WITHOUT POST-OPERATIVE ADJUVA... | {
"A": "Intervention Type: DRUG; Name: fluorouracil; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: leucovorin calcium; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: conventional surgery; Assigned to Arm(s): N/A | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): N/A... | A | [
"NCT00002523",
"NCT00700102",
"NCT00677443",
"NCT00561470"
] | 151 | train |
NCT00002523 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: FOUR ARMS PHASE III CLINICAL TRIAL FOR T3-T4 RESECTABLE RECTAL CANCER COMPARING PRE-OPERATIVE PELVIC IRRADIATION TO PRE-OPERATIVE IRRADIATION COMBINED WITH FLUOROURACIL AND LEUCOVORIN WITH OR WITHOUT POST-OPERATIVE ADJUVA... | {
"A": "Arm Label: Treatment (capecitabine, oxaliplatin, radiotherapy, surgery); Type: EXPERIMENTAL; Interventions: Drug: capecitabine, Drug: oxaliplatin, Procedure: neoadjuvant therapy, Radiation: radiation therapy | Intervention Type: DRUG; Name: capecitabine; Assigned to Arm(s): Treatment (capecitabine, oxaliplati... | D | [
"NCT00114231",
"NCT02945566",
"NCT01308190",
"NCT00002523"
] | 152 | train |
NCT00002540 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
Brief Summary: This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduc... | {
"A": "Intervention Type: DRUG; Name: hormone replacement therapy; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogens; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: progestins; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogen replacement therapy; Assigned to Arm(s): N/A | ... | C | [
"NCT00000611",
"NCT00270647",
"NCT00002540",
"NCT00006392"
] | 153 | train |
NCT00002561 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Study of Radiotherapy or ABVD Plus Radiotherapy Versus ABVD Alone in the Treatment of Early Stage Hodgkin's Disease
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells f... | {
"A": "Arm Label: Arm A (ABVD); Type: EXPERIMENTAL; Interventions: Drug: Doxorubicin, Drug: Bleomycin, Drug: Vinblastine, Drug: Dacarbazine, Radiation: Radiotherapy | Arm Label: Arm B (Stanford V); Type: ACTIVE_COMPARATOR; Interventions: Drug: Doxorubicin, Drug: Bleomycin, Drug: Vinblastine, Drug: Vincristine, Drug:... | C | [
"NCT00003389",
"NCT00265018",
"NCT00002561",
"NCT00379041"
] | 154 | train |
NCT00002561 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Study of Radiotherapy or ABVD Plus Radiotherapy Versus ABVD Alone in the Treatment of Early Stage Hodgkin's Disease
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells f... | {
"A": "Arm Label: Favorable - Standard - any PET outcome; Type: ACTIVE_COMPARATOR; Interventions: Drug: ABVD q4 weeks, Radiation: IN-RT 30 Gy (+ boost 6 Gy residual), Procedure: FDG-PET scan | Arm Label: Favorable - Experimental - PET negative; Type: EXPERIMENTAL; Interventions: Drug: ABVD q4 weeks, Procedure: FDG-P... | C | [
"NCT00433433",
"NCT00025259",
"NCT00002561",
"NCT00943423"
] | 155 | train |
NCT00002569 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Intergroup Randomized Comparison of Radiation Alone vs. Pre-Radiation Chemotherapy for Pure and Mixed Anaplastic Oligodendrogliomas
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop... | {
"A": "Arm Label: Observation; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Radiation therapy; Type: EXPERIMENTAL; Interventions: Radiation: radiation therapy | Arm Label: Radiation plus PCV chemotherapy; Type: EXPERIMENTAL; Interventions: Drug: lomustine, Drug: procarbazine hydrochloride, Drug: vincristin... | C | [
"NCT00003375",
"NCT00517959",
"NCT00002569",
"NCT00182819"
] | 156 | train |
NCT00002569 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Intergroup Randomized Comparison of Radiation Alone vs. Pre-Radiation Chemotherapy for Pure and Mixed Anaplastic Oligodendrogliomas
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop... | {
"A": "Arm Label: Radiation therapy (RT) alone; Type: ACTIVE_COMPARATOR; Interventions: Radiation: radiation therapy | Arm Label: Intensive pre-treatment chemotherapy and radiation therapy; Type: EXPERIMENTAL; Interventions: Drug: lomustine, Drug: procarbazine hydrochloride, Drug: vincristine sulfate, Radiation: rad... | A | [
"NCT00002569",
"NCT01450449",
"NCT00006353",
"NCT00430911"
] | 157 | train |
NCT00002641 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: RANDOMISED TRIAL OF ADJUVANT CHEMOTHERAPY WITH HIGH-DOSE DOXORUBICIN, IFOSFAMIDE AND LENOGRASTIM IN HIGH GRADE SOFT TISSUE SARCOMA
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell... | {
"A": "Arm Label: Group 1; Type: EXPERIMENTAL; Interventions: Biological: dactinomycin, Drug: doxorubicin hydrochloride, Drug: etoposide, Drug: ifosfamide, Drug: vincristine sulfate, Procedure: conventional surgery, Radiation: radiation therapy | Arm Label: Group 2, arm I; Type: EXPERIMENTAL; Interventions: Biologic... | D | [
"NCT00020566",
"NCT00006734",
"NCT01343277",
"NCT00002641"
] | 158 | train |
NCT00002720 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: QUADRANTECTOMY PLUS AXILLARY DISSECTION VERSUS QUADRANTECTOMY ALONE IN MAMMOGRAPHIC STAGE T1N0 BREAST CANCER PATIENTS AGED OVER 65 YEARS
Brief Summary: RATIONALE: Surgery to remove axillary lymph nodes may be an effective... | {
"A": "Arm Label: Arm I: Conventional axillary dissection; Type: ACTIVE_COMPARATOR; Interventions: Procedure: conventional surgery | Arm Label: Arm II: Sentinel node resection followed by node examination; Type: EXPERIMENTAL; Interventions: Procedure: Sentinel node resection followed by node examination | Interventi... | B | [
"NCT00003830",
"NCT00002720",
"NCT00014612",
"NCT00072293"
] | 159 | train |
NCT00002803 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: COOPERATIVE MULTICENTER TRIAL FOR THE TREATMENT OF INFANTS WITH NEUROBLASTOMA
Brief Summary: RATIONALE: Sometimes neuroblastoma will regress without treatment, but sometimes additional treatment may be necessary. Giving m... | {
"A": "Arm Label: R0: COJEC plus G-CSF; Type: EXPERIMENTAL; Interventions: Drug: Carboplatin, Drug: Etoposide, Drug: Cisplatin, Drug: Cyclophosphamide, Drug: G-CSF | Arm Label: R0: COJEC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vincristine, Drug: Carboplatin, Drug: Etoposide, Drug: Cisplatin, Drug: Cyclophosph... | D | [
"NCT01704716",
"NCT00365755",
"NCT00017225",
"NCT00002803"
] | 160 | train |
NCT00002803 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: COOPERATIVE MULTICENTER TRIAL FOR THE TREATMENT OF INFANTS WITH NEUROBLASTOMA
Brief Summary: RATIONALE: Sometimes neuroblastoma will regress without treatment, but sometimes additional treatment may be necessary. Giving m... | {
"A": "Intervention Type: DRUG; Name: carboplatin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: cisplatin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: cyclophosphamide; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: etoposide; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name... | C | [
"NCT00365755",
"NCT00004188",
"NCT00002803",
"NCT00017225"
] | 161 | train |
NCT00002840 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: PHASE III STUDY OF ADJUVANT PROCARBAZINE, CCNU AND VINCRISTINE CHEMOTHERAPY IN PATIENTS WITH HIGHLY ANAPLASTIC OLIGODENDROGLIOMA
Brief Summary: RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells, a... | {
"A": "Intervention Type: DRUG; Name: temozolomide; Assigned to Arm(s): N/A | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): N/A",
"B": "Arm Label: Radiation therapy (RT) alone; Type: ACTIVE_COMPARATOR; Interventions: Radiation: radiation therapy | Arm Label: Intensive pre-treatment che... | C | [
"NCT00006353",
"NCT00002569",
"NCT00002840",
"NCT00482677"
] | 162 | train |
NCT00002899 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Trial on Convergent Beam Irradiation of Cerebral Metastases
Brief Summary: RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Adjuvant radiation therapy may kill any remaining tumor cell... | {
"A": "Arm Label: Arm I - WBRT; Type: ACTIVE_COMPARATOR; Interventions: Radiation: whole-brain radiation therapy | Arm Label: Arm II - SRS; Type: EXPERIMENTAL; Interventions: Radiation: stereotactic radiosurgery | Intervention Type: RADIATION; Name: stereotactic radiosurgery; Assigned to Arm(s): Arm II - SRS | Inter... | B | [
"NCT01372774",
"NCT00002899",
"NCT00124761",
"NCT00950001"
] | 163 | train |
NCT00003232 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Placebo-Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone Alone in Patients With Hormone Refractory Metastatic Prostate Cancer and Pain
Brief Summary: RATIONALE: Some dru... | {
"A": "Arm Label: Experimental Arm; Type: EXPERIMENTAL; Interventions: Drug: Risedronate | Arm Label: Placebo Arm; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Risedronate; Assigned to Arm(s): Experimental Arm | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Pl... | D | [
"NCT00216060",
"NCT00019695",
"NCT00685646",
"NCT00003232"
] | 164 | train |
NCT00003375 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase II Study of Radiation With or Without PCV Chemotherapy in Unfavorable Low-Grade Glioma
Brief Summary: RATIONALE: Radiation therapy uses high-energy... | {
"A": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Radiation: Stereotactic Conformal radiotherapy | Arm Label: 2; Type: OTHER; Interventions: Radiation: Conventional radiotherapy | Intervention Type: RADIATION; Name: Stereotactic Conformal radiotherapy; Assigned to Arm(s): 1 | Intervention Type: RADIATION; Name... | C | [
"NCT00517959",
"NCT00182819",
"NCT00003375",
"NCT00589875"
] | 165 | train |
NCT00003389 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Phase III Trial of ABVD Versus Stanford V (+/-) Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop canc... | {
"A": "Arm Label: Arm A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Adriamycin, Drug: Bleomycin, Drug: Vinblastine, Drug: DTIC, Radiation: 30 Gy IF-RT | Arm Label: Arm B; Type: EXPERIMENTAL; Interventions: Drug: Adriamycin, Drug: Bleomycin, Drug: Vinblastine, Drug: DTIC, Radiation: 20 Gy IF-RT | Arm Label: Arm C;... | B | [
"NCT00265018",
"NCT00003389",
"NCT00379041",
"NCT00433433"
] | 166 | train |
NCT00003636 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Phase III Study Comparing Upfront Debulking Surgery Versus Neo-Adjuvant Chemotherapy in Patients With Stage IIIC or IV Epithelial Ovarian Carcinoma
Brief Summary: RATIONALE: Drugs used in chemotherapy use dif... | {
"A": "Arm Label: Arm I PDS and chemotherapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: PDS (Primary Debulkdung Surgery), Procedure: 6 cycles of standard chemotherapy | Arm Label: Arm II Timing of surgery after 3 cycles of SOC CTX; Type: EXPERIMENTAL; Interventions: Procedure: Timing of surgery after 3 cycl... | C | [
"NCT02828618",
"NCT01461850",
"NCT00003636",
"NCT00262847"
] | 167 | train |
NCT00003636 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Phase III Study Comparing Upfront Debulking Surgery Versus Neo-Adjuvant Chemotherapy in Patients With Stage IIIC or IV Epithelial Ovarian Carcinoma
Brief Summary: RATIONALE: Drugs used in chemotherapy use dif... | {
"A": "Intervention Type: DRUG; Name: carboplatin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: cisplatin; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: conventional surgery; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: neoadjuvant therapy; Assigned to Arm(s): N/A",
"B"... | A | [
"NCT00003636",
"NCT00862836",
"NCT01447706",
"NCT00696670"
] | 168 | train |
NCT00003636 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Phase III Study Comparing Upfront Debulking Surgery Versus Neo-Adjuvant Chemotherapy in Patients With Stage IIIC or IV Epithelial Ovarian Carcinoma
Brief Summary: RATIONALE: Drugs used in chemotherapy use dif... | {
"A": "Arm Label: Arm I PDS and chemotherapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: PDS (Primary Debulkdung Surgery), Procedure: 6 cycles of standard chemotherapy | Arm Label: Arm II Timing of surgery after 3 cycles of SOC CTX; Type: EXPERIMENTAL; Interventions: Procedure: Timing of surgery after 3 cycl... | B | [
"NCT02828618",
"NCT00003636",
"NCT00712218",
"NCT01461850"
] | 169 | train |
NCT00003787 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study
Brief Summary: RATIONALE: Dietary fats, fruits, vegetables, and fiber m... | {
"A": "Arm Label: Walnut group; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Walnuts | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: habitual diet | Intervention Type: DIETARY_SUPPLEMENT; Name: Walnuts; Assigned to Arm(s): Walnut group | Intervention Type: OTHER; Name: habit... | B | [
"NCT01634841",
"NCT00003787",
"NCT01005498",
"NCT00274729"
] | 170 | train |
NCT00003787 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study
Brief Summary: RATIONALE: Dietary fats, fruits, vegetables, and fiber m... | {
"A": "Intervention Type: BEHAVIORAL; Name: Intensive dietary advice; Assigned to Arm(s): N/A",
"B": "Arm Label: Probiotics; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Probiotics | Arm Label: Probiotics + Dietary counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary counselling and probiot... | C | [
"NCT00124553",
"NCT00167700",
"NCT00003787",
"NCT00143936"
] | 171 | train |
NCT00003787 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study
Brief Summary: RATIONALE: Dietary fats, fruits, vegetables, and fiber m... | {
"A": "Intervention Type: DRUG; Name: hormone replacement therapy; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogens; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: progestins; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogen replacement therapy; Assigned to Arm(s): N/A | ... | C | [
"NCT00000611",
"NCT00124553",
"NCT00003787",
"NCT00160108"
] | 172 | train |
NCT00003787 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study
Brief Summary: RATIONALE: Dietary fats, fruits, vegetables, and fiber m... | {
"A": "Intervention Type: DRUG; Name: hormone replacement therapy; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogens; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: progestins; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: estrogen replacement therapy; Assigned to Arm(s): N/A | ... | D | [
"NCT00000611",
"NCT00352170",
"NCT01166165",
"NCT00003787"
] | 173 | train |
NCT00003787 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study
Brief Summary: RATIONALE: Dietary fats, fruits, vegetables, and fiber m... | {
"A": "Arm Label: Intervention; Type: N/A; Interventions: Behavioral: educational/counseling intervention, Behavioral: therapeutic dietary intervention | Arm Label: Control; Type: N/A; Interventions: Behavioral: therapeutic dietary intervention | Intervention Type: BEHAVIORAL; Name: educational/counseling interventi... | A | [
"NCT00003787",
"NCT00276939",
"NCT00622960",
"NCT00000611"
] | 174 | train |
NCT00003787 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study
Brief Summary: RATIONALE: Dietary fats, fruits, vegetables, and fiber m... | {
"A": "Arm Label: DIPI: Danish national dietary guidelines; Type: ACTIVE_COMPARATOR; Interventions: Other: DIPI | Arm Label: DIPI: Specific IHD dietary guideline; Type: ACTIVE_COMPARATOR; Interventions: Other: DIPI | Arm Label: Normal dietary habits; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTH... | D | [
"NCT02062424",
"NCT01513798",
"NCT00622960",
"NCT00003787"
] | 175 | train |
NCT00003787 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study
Brief Summary: RATIONALE: Dietary fats, fruits, vegetables, and fiber m... | {
"A": "Arm Label: dietary; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary | Arm Label: physical activity; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Arm Label: dietary and physical activity; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary, Behavioral: Physical activity | Arm La... | B | [
"NCT01708824",
"NCT00003787",
"NCT01527409",
"NCT01512069"
] | 176 | train |
NCT00003787 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study
Brief Summary: RATIONALE: Dietary fats, fruits, vegetables, and fiber m... | {
"A": "Intervention Type: BEHAVIORAL; Name: dietary intervention; Assigned to Arm(s): N/A",
"B": "Intervention Type: BEHAVIORAL; Name: diet, sodium-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: diet, fat-restricted; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: exercis... | C | [
"NCT00160108",
"NCT00000616",
"NCT00003787",
"NCT00622960"
] | 177 | train |
NCT00003787 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dietary Intervention in Women Who Have Been Treated For Stage I, Stage II, or Stage III Breast Cancer: Women's Healthy Eating and Living (WHEL) Study
Brief Summary: RATIONALE: Dietary fats, fruits, vegetables, and fiber m... | {
"A": "Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Attention Control (Health Education); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control (Health Education) | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise | Intervention ... | D | [
"NCT02056067",
"NCT01515124",
"NCT00303875",
"NCT00003787"
] | 178 | train |
NCT00003830 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Phase III Clinical Trial to Compare Sentinel Node Resection to Conventional Axillary Dissection in Clinically Node-Negative Breast Cancer Patients
Brief Summary: RATIONALE: Removing the sentinel lymph nodes ... | {
"A": "Arm Label: Arm I: Conventional axillary dissection; Type: ACTIVE_COMPARATOR; Interventions: Procedure: conventional surgery | Arm Label: Arm II: Sentinel node resection followed by node examination; Type: EXPERIMENTAL; Interventions: Procedure: Sentinel node resection followed by node examination | Interventi... | A | [
"NCT00003830",
"NCT00014612",
"NCT00072293",
"NCT00210236"
] | 179 | train |
NCT00003855 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node
Brief Summary: RATIONALE: Surgery to remove lymph nodes in the armpit may remove cancer ce... | {
"A": "Arm Label: Axillary Dissection; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Axillary lymph node dissection | Arm Label: No Axillary Dissection; Type: EXPERIMENTAL; Interventions: Procedure: No axillary lymph node dissection | Intervention Type: PROCEDURE; Name: Axillary lymph node dissection; Assigned ... | C | [
"NCT00072293",
"NCT00014612",
"NCT00003855",
"NCT00003830"
] | 180 | train |
NCT00003888 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Phase III Multicenter Trial of Neoadjuvant Docetaxel (Taxotere) Plus Cisplatin Plus 5-Fluorouracil Versus Neoadjuvant Cisplatin Plus 5-Fluorouracil in Patients With Locally Advanced Inoperable Squamous Cell C... | {
"A": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Docetaxel, Cisplatin, 5-fluorouracil (5-FU), radiotherapy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Cisplatin, 5-fluorouracil (5-FU), radiotherapy | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Other: Cisplatin + radiotherapy | Interven... | C | [
"NCT00261703",
"NCT01126216",
"NCT00003888",
"NCT00004227"
] | 181 | train |
NCT00003906 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
Brief Summary: RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using raloxifene and tamoxifen may fight bre... | {
"A": "Arm Label: Group 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tamoxifen | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Drug: Raloxifene | Intervention Type: DRUG; Name: Raloxifene; Assigned to Arm(s): Group 2 | Intervention Type: DRUG; Name: Tamoxifen; Assigned to Arm(s): Group 1",
"B": "Arm L... | A | [
"NCT00003906",
"NCT01077453",
"NCT00000479",
"NCT00519857"
] | 182 | train |
NCT00004067 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial Comparing the Safety and Efficacy of Adriamycin and Cyclophosphamide Followed by Taxol (AC-T) to That of Adriamycin and Cyclophosphamide Followed by Taxol Plus Herceptin (AC-T+H) in Node-Positive Breast... | {
"A": "Arm Label: Arm 1: adriamycin + cyclophosphamide then taxol; Type: ACTIVE_COMPARATOR; Interventions: Drug: adriamycin, Drug: cyclophosphamide, Drug: taxol | Arm Label: Arm 2: adriamycin + cyclophosphamide then taxol + herceptin; Type: EXPERIMENTAL; Interventions: Biological: herceptin, Drug: adriamycin, Drug: ... | A | [
"NCT00004067",
"NCT01266642",
"NCT00459628",
"NCT00005970"
] | 183 | train |
NCT00004067 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial Comparing the Safety and Efficacy of Adriamycin and Cyclophosphamide Followed by Taxol (AC-T) to That of Adriamycin and Cyclophosphamide Followed by Taxol Plus Herceptin (AC-T+H) in Node-Positive Breast... | {
"A": "Arm Label: Arm I (AC, paclitaxel, tamoxifen, aromatase inhibitor); Type: EXPERIMENTAL; Interventions: Drug: Aromatase Inhibition Therapy, Drug: Cyclophosphamide, Drug: Doxorubicin Hydrochloride, Other: Laboratory Biomarker Analysis, Drug: Paclitaxel, Drug: Tamoxifen Citrate | Arm Label: Arm II (AC, paclitaxel... | B | [
"NCT00005970",
"NCT00004067",
"NCT00045032",
"NCT00629278"
] | 184 | train |
NCT00004125 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Study of Doxorubicin-Cyclophosphamide Therapy Followed by Paclitaxel or Docetaxel Given Weekly or Every 3 Weeks in Patients With Axillary Node-Positive Breast Cancer
Brief Summary: RATIONALE: Drugs used in che... | {
"A": "Arm Label: A:Paclitaxel + Carboplatin every 3 weeks; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel + Carboplatin every 3 weeks | Arm Label: B:Carboplatin monotherapy every 3 weeks; Type: EXPERIMENTAL; Interventions: Drug: Carboplatin monotherapy every 3 weeks | Arm Label: C:Weekly Paclitaxel and Carbopl... | D | [
"NCT02001272",
"NCT00262847",
"NCT00426257",
"NCT00004125"
] | 185 | train |
NCT00004125 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Study of Doxorubicin-Cyclophosphamide Therapy Followed by Paclitaxel or Docetaxel Given Weekly or Every 3 Weeks in Patients With Axillary Node-Positive Breast Cancer
Brief Summary: RATIONALE: Drugs used in che... | {
"A": "Arm Label: Arm I (CA for 4 courses); Type: ACTIVE_COMPARATOR; Interventions: Drug: AC regimen, Drug: doxorubicin hydrochloride | Arm Label: Arm II (CA for 6 courses [closed to accrual 12/15/2007]); Type: EXPERIMENTAL; Interventions: Drug: AC regimen, Drug: cyclophosphamide, Drug: doxorubicin hydrochloride | A... | D | [
"NCT00041119",
"NCT01222052",
"NCT00331097",
"NCT00004125"
] | 186 | train |
NCT00004188 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Study of Purged Versus Unpurged Peripheral Blood Stem Cell Transplant Following Dose Intensive Induction Therapy for High Risk Neuroblastoma
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ... | {
"A": "Arm Label: R0: COJEC plus G-CSF; Type: EXPERIMENTAL; Interventions: Drug: Carboplatin, Drug: Etoposide, Drug: Cisplatin, Drug: Cyclophosphamide, Drug: G-CSF | Arm Label: R0: COJEC; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vincristine, Drug: Carboplatin, Drug: Etoposide, Drug: Cisplatin, Drug: Cyclophosph... | B | [
"NCT01704716",
"NCT00004188",
"NCT00002803",
"NCT00017225"
] | 187 | train |
NCT00004188 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Study of Purged Versus Unpurged Peripheral Blood Stem Cell Transplant Following Dose Intensive Induction Therapy for High Risk Neuroblastoma
Brief Summary: RATIONALE: Drugs used in chemotherapy use different ... | {
"A": "Intervention Type: DRUG; Name: cyclophosphamide; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: doxorubicin hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: vincristine sulfate; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: conventional surgery; Assigned to Arm... | D | [
"NCT00002803",
"NCT00017225",
"NCT00365755",
"NCT00004188"
] | 188 | train |
NCT00004205 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Study to Evaluate Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women With Receptor (ER and/or PgR) Positive Tumors
Brief Summary: RATIONALE: Estrogen can stimulate the growth of breast cancer cel... | {
"A": "Arm Label: Tamoxifen; Type: EXPERIMENTAL; Interventions: Drug: tamoxifen citrate | Arm Label: Letrozole; Type: EXPERIMENTAL; Interventions: Drug: letrozole | Arm Label: Tamoxifen, then letrozole; Type: EXPERIMENTAL; Interventions: Drug: letrozole, Drug: tamoxifen citrate | Arm Label: Letrozole, then tamoxifen... | A | [
"NCT00004205",
"NCT01573442",
"NCT00489411",
"NCT00066690"
] | 189 | train |
NCT00004227 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Phase III Trial to Compare Radiation Therapy Alone With Radiation Therapy and Concomitant Anti-EGFr Antibody (C225) for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
Brief Summary: RATIONALE: R... | {
"A": "Intervention Type: DRUG; Name: cetuximab; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Cisplatin; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Radiotherapy 70 Gy, 35 fractions; Assigned to Arm(s): N/A",
"B": "Arm Label: Group 1; Type: EXPERIMENTAL; Interventions: Biological: cet... | C | [
"NCT00169247",
"NCT01084083",
"NCT00004227",
"NCT00122460"
] | 190 | train |
NCT00004227 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Phase III Trial to Compare Radiation Therapy Alone With Radiation Therapy and Concomitant Anti-EGFr Antibody (C225) for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
Brief Summary: RATIONALE: R... | {
"A": "Intervention Type: DRUG; Name: cisplatin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: docetaxel; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: fluorouracil; Assigned to Arm(s): N/A | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): N/A",
"B": "Arm Label: Ind... | C | [
"NCT00003888",
"NCT00828386",
"NCT00004227",
"NCT02105636"
] | 191 | train |
NCT00004227 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Phase III Trial to Compare Radiation Therapy Alone With Radiation Therapy and Concomitant Anti-EGFr Antibody (C225) for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
Brief Summary: RATIONALE: R... | {
"A": "Arm Label: Arm I; Type: PLACEBO_COMPARATOR; Interventions: Procedure: conventional surgery, Radiation: radiation therapy | Arm Label: Arm II; Type: ACTIVE_COMPARATOR; Interventions: Biological: cetuximab, Procedure: conventional surgery, Radiation: radiation therapy | Intervention Type: BIOLOGICAL; Name: cetu... | A | [
"NCT00004227",
"NCT00779389",
"NCT00169221",
"NCT00410826"
] | 192 | train |
NCT00004428 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: OBJECTIVES: I. Evaluate the safety of ascending doses of CPX administered to adult patients with mild cystic fibrosis.
II. Evaluate the pharmacokinetics of ascending doses of CPX in this patient popula... | {
"A": "Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: LUM 600 mg qd/IVA 250 mg q12h; Type: EXPERIMENTAL; Interventions: Drug: Lumacaftor Plus Ivacaftor Combination, Drug: Ivacaftor | Arm Label: LUM 400 mg q12h/ IVA 250 mg q12h; Type: EXPERIMENTAL; Interventions: Drug: Lumacaf... | C | [
"NCT01807949",
"NCT03119649",
"NCT00004428",
"NCT02275936"
] | 193 | train |
NCT00004428 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: OBJECTIVES: I. Evaluate the safety of ascending doses of CPX administered to adult patients with mild cystic fibrosis.
II. Evaluate the pharmacokinetics of ascending doses of CPX in this patient popula... | {
"A": "Intervention Type: DRUG; Name: CPX; Assigned to Arm(s): N/A",
"B": "Arm Label: PTC124 PO; Type: EXPERIMENTAL; Interventions: Drug: PTC124 | Intervention Type: DRUG; Name: PTC124; Assigned to Arm(s): PTC124 PO",
"C": "Arm Label: Placebo (pooled two times a day [BID]/three times a day [TID]); Type: PLACEBO_... | A | [
"NCT00004428",
"NCT00351078",
"NCT00104520",
"NCT00458341"
] | 194 | train |
NCT00004465 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated
Brief Summary: OBJECTIVES: I. Determine the effect of SYNSORB Pk therapy on mortality and frequency of severe extrarenal complications observed ... | {
"A": "Arm Label: SYNSORB Pk; Type: EXPERIMENTAL; Interventions: Drug: SYNSORB Pk | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: SYNSORB Pk; Assigned to Arm(s): SYNSORB Pk | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo",
"B": "Ar... | A | [
"NCT00004465",
"NCT01252199",
"NCT03275792",
"NCT04132375"
] | 195 | train |
NCT00004467 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: OBJECTIVES:
I. Determine the safety and efficacy of a short course (72 hours) of intravenous acetylcysteine in patients with acute liver failure for whom no antidote or specific treatment is available.... | {
"A": "Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: N-acetylcysteine (NAC); Type: EXPERIMENTAL; Interventions: Drug: N-acetylcysteine (NAC) | Intervention Type: DRUG; Name: N-acetylcysteine (NAC); Assigned to Arm(s): N-acetylcysteine (NAC) | Intervention Type: DRUG; Name: P... | A | [
"NCT00004467",
"NCT00334191",
"NCT00211653",
"NCT00332631"
] | 196 | train |
NCT00004486 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: OBJECTIVES: I. Evaluate the efficacy of fluoxetine on social and language deficits, global severity and compulsive dimensions of children and adolescents with autism.
II. Assess the effectiveness of th... | {
"A": "Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: RO5028442 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: RO5028442; Assigned to Arm(s): 1",
"B": "Intervention Type: DRUG; Name: flu... | B | [
"NCT01474278",
"NCT00004486",
"NCT01914939",
"NCT01944046"
] | 197 | train |
NCT00004486 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: OBJECTIVES: I. Evaluate the efficacy of fluoxetine on social and language deficits, global severity and compulsive dimensions of children and adolescents with autism.
II. Assess the effectiveness of th... | {
"A": "Arm Label: Lurasidone 20 mg; Type: EXPERIMENTAL; Interventions: Drug: Lurasidone 20 mg daily | Arm Label: Lurasidone 60 mg; Type: EXPERIMENTAL; Interventions: Drug: Lurasidone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lurasidone 20 mg daily; ... | B | [
"NCT01911442",
"NCT00004486",
"NCT00453180",
"NCT01333072"
] | 198 | train |
NCT00004486 | Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: OBJECTIVES: I. Evaluate the efficacy of fluoxetine on social and language deficits, global severity and compulsive dimensions of children and adolescents with autism.
II. Assess the effectiveness of th... | {
"A": "Arm Label: Transdermal nicotine first, placebo last; Type: EXPERIMENTAL; Interventions: Drug: Transdermal nicotine, Other: Transdermal placebo | Arm Label: Transdermal placebo first, nicotine last; Type: EXPERIMENTAL; Interventions: Drug: Transdermal nicotine, Other: Transdermal placebo | Intervention Type: D... | B | [
"NCT02552147",
"NCT00004486",
"NCT01337687",
"NCT00178503"
] | 199 | train |